These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7691618)

  • 1. Substance P-(1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice.
    Kreeger JS; Larson AA
    Eur J Pharmacol; 1993 Jul; 238(1):111-5. PubMed ID: 7691618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
    Kreeger JS; Larson AA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intrathecal pretreatment with the neurokinin receptor antagonist CP-99994 on the expression of naloxone-precipitated morphine withdrawal symptoms.
    Buccafusco JJ; Shuster LC
    Brain Res Bull; 1997; 43(3):321-6. PubMed ID: 9227843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting and evoked spinal substance P release during chronic intrathecal morphine infusion: parallels with tolerance and dependence.
    Gu G; Kondo I; Hua XY; Yaksh TL
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1362-9. PubMed ID: 15908510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenothiazine-type antipsychotics may attenuate naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Wu SZ; Chen KT; Chen JY; Sung KC; Wang JJ; Liu KS; Chu CC
    Acta Anaesthesiol Taiwan; 2012 Dec; 50(4):167-71. PubMed ID: 23385039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R; Girdlestone D; Roques BP
    Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effects by cysteine protease inhibitors on naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Tan-No K; Sato T; Shimoda M; Nakagawasai O; Niijima F; Kawamura S; Furuta S; Sato T; Satoh S; Silberring J; Terenius L; Tadano T
    Neuropeptides; 2010 Jun; 44(3):279-83. PubMed ID: 20189644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs.
    Johnston PA; Chahl LA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Mar; 343(3):283-8. PubMed ID: 1714041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of spinal neuropeptides and prostaglandins in opioid physical dependence.
    Trang T; Sutak M; Quirion R; Jhamandas K
    Br J Pharmacol; 2002 May; 136(1):37-48. PubMed ID: 11976266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excess release of substance P from the spinal cord of mice during morphine withdrawal and involvement of the enhancement of presynaptic Ca2+ entry.
    Ueda H; Tamura S; Satoh M; Takagi H
    Brain Res; 1987 Nov; 425(1):101-5. PubMed ID: 2448001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of naloxone-precipitated withdrawal jumping by i.c.v. and i.t. administration of saline in morphine-dependent mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(13):1129-34. PubMed ID: 8450707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acutely administered clozapine does not modify naloxone-induced withdrawal jumping in morphine-dependent mice.
    Ballard TM; McAllister KH
    Pharmacol Biochem Behav; 1999 Feb; 62(2):285-90. PubMed ID: 9972695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR; Mohajeri S
    Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of beta-adrenoceptors in the expression of morphine withdrawal signs.
    Funada M; Suzuki T; Sugano Y; Tsubai M; Misawa M; Ueda H; Misu Y
    Life Sci; 1994; 54(8):PL113-8. PubMed ID: 7509021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice.
    Zarrindast MR; Farzin D
    Eur J Pharmacol; 1996 Feb; 298(1):1-6. PubMed ID: 8867912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration in the brain content of substance P (1-7) during withdrawal in morphine-dependent rats.
    Zhou Q; Liu Z; Ray A; Huang W; Karlsson K; Nyberg F
    Neuropharmacology; 1998 Dec; 37(12):1545-52. PubMed ID: 9886677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
    Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
    Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased antagonist potency of naloxone caused by morphine pretreatment in mice.
    Wong CL; Bentley CA
    Eur J Pharmacol; 1978 Feb; 47(4):415-22. PubMed ID: 564774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.